Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Andrew Feldstein and Stephen Siderow Join a REIT Party

BlueMountain Capital, Chatham Lodging Trust: In a new 13D with the SEC minutes ago, Andrew Feldstein and Stephen Siderow’s BlueMountain Capital disclosed a 4.9% stake in hotel REIT Chatham Lodging Trust (NYSE:CLDT). HG Vora Capital Management reported a similar sized position a few minutes earlier, and like Vora, BlueMountain also mentions that its investment is in anticipation of talks to “enhance value” for shareholders. We’ll keep watching this situation to deliver any updates on what this value creation might be, whether it’s in the form of a dividend boost, a share buyback, or something else altogether.

Andrew Feldstein and Stephen Siderow


Chatham Lodging Trust disclosed last week that it was buying the 180-room Hilton Garden Inn Denver Tech Center for a price of $27.9 million. The Center hosts offices of more than 1,000 companies with Oracle, Newmont Mining, EMC Corporation and IBM among them. At the end of September, the company conducted a public offering of around 3.3 million shares at a price of $18.50 per share, with a total gross proceeds worth some $59.6 million. The proceeds were used for the acquisition of Garden Inn Denver Tech Center, as well as for the purchase of the 231-room Residence Inn Seattle Bellevue, worth $73.2 million.

J. Alan Reid Jr.’s Forward Management and Israel Englander’s Millennium Management own shares of Chatham Lodging Trust.

Disclosure: none

Recommended Reading:

HG Vora Capital Wants to ‘Enhance Value’ at Chatham Lodging REIT

Hedge Fund Week in Review: Activist Action

Kopp Investment Advisors Ups Stake in Mindspeed Technologies by 20%

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!